(11) | Number of the document | 4496 |
(21) | Number of the application | a 2014 0112 |
(22) | Filing date of the application | 2013.03.11 |
| Date of filing the request for examination | (de fond) 07.04.2017 |
(71) | Name(s) of applicant(s), code of the country | GILEAD SCIENCES, INC., US; |
(72) | Name(s) of inventor(s), code of the country | CLARKE Michael O'Neil Hanrahan, US; |
(73) | Name(s) of owner(s), code of the country | GILEAD SCIENCES, INC., US; |
(54) | Title of the invention | 2'-Substituted carba-nucleoside analogs for antiviral treatment
|
(13) | Kind-of-document code | |
(51) | International Patent Classification | C07H 19/23 (2006.01); A61K 31/706 (2006.01); A61P 31/16 (2006.01); |
(19) | Country | US |
(41) | Date of publication of the application | 2015.02.28 |
(45) | Date of publication of patent granting decision: | 2017.07.31 |
(47) | Date of issuance of patent | 2018.02.28 |
(30) | Priority | 61/610411, 2012.03.13, US |
(74) | Patent attorney | MARGINE Ion, Str. Lomonosov nr. 43, ap. 23, MD-2009, Chişinău, Republica Moldova |
| Substantive examiner(s) | JOVMIR Tudor |
(85) | Date of introducing the national procedure | 2014.10.10 |
(86) | International application | PCT/US2013/030196, 2013.03.11 |
(87) | International publication | WO 2013/138236 A1, 2013.09.19 |
| Payment for maintenance up to the date | 2025.03.11 |